Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)

Federal funding opportunity PAR-27-003 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes September 26, 2029

Program funding history

Synopsis

Who can apply

• City or township governments
• For profit organizations other than small businesses
• County governments
• Special district governments
• Public housing authorities/Indian housing authorities
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Public and State controlled institutions of higher education
• State governments
• Native American tribal governments (Federally recognized)
• Native American tribal organizations (other than Federally recognized tribal governments)
• Private institutions of higher education
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Independent school districts
• Small businesses

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibilityForeign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards. Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

How to apply

Similar grants

• Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
  PAR-25-296 · National Institutes of Health · closes October 19, 2027
• Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimer’s and Related Dementias Disease Risk
  PAR-26-067 · National Institutes of Health
• Renewal of NIA Research Centers Collaborative Network (RCCN)
  RFA-AG-26-026 · National Institutes of Health
• NEI Collaborative Clinical Vision Research (UG1 - Clinical Trial Optional)
  PAR-26-119 · National Institutes of Health
• Collaborative Network for Clinical Research on Immune Tolerance
  RFA-AI-28-005 · National Institutes of Health
• Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)
  RFA-AA-28-002 · National Institutes of Health